RxDoctor Payments Data

David Band, MD

Psychiatry · Ashburn, VANPI 1043316094

Payments from drug & device makers

$947in general payments, 2019–2025

Across 62 payments — averaging $15.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sunovion Pharmaceuticals Inc.$317
  • Johnson & Johnson$200
  • Lundbeck LLC$66
  • Takeda Pharmaceuticals U.S.A., Inc.$56
  • Shire North American Group Inc$55
  • Otsuka America Pharmaceutical, Inc.$45
  • plus $208 from 8 others

What the payments were for

  • Food & beverage$947100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$947 in reported general payments places this provider in the 70th percentile of 884 psychiatry providers in Virginia.

See all psychiatry providers in Virginia

Medicare billing

Part B allowed, 2024
$10,890
Medicare patients
17
Services billed
96

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tiagabine Hcl48$16,978
VyvanseLisdexamfetamine Dimesylate25$11,937
Ziprasidone Hcl61$10,504
Fluvoxamine Maleate60$5,212
Lisdexamfetamine Dimesylate18$4,325
Haloperidol50$4,165
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine69$3,771
Aripiprazole36$2,299
Oxcarbazepine54$2,210
Olanzapine60$2,199
Eszopiclone22$2,023
Risperidone94$2,007
Duloxetine Hcl25$1,883
Divalproex Sodium30$1,821
Divalproex Sodium ErDivalproex Sodium26$1,468

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$56$11,93725 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 884 psychiatry providers in Virginia.

Other psychiatry in Ashburn

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →